Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Jonathan Licht
DNA biology, myeloma
Simona Colla
Myeloma biology
Lev Kats
myeloma and epigenetics
Armin Rashidi
gut bacteria and transplant success
Jianhua Yu
myeloma immunotherapy
Paul Beavis
immunotherapy in myeloma
Caroline Arber
myeloma CAR-T
Amin Sobh
Myeloma biology
Suzanne Lentzsch
Myeloma
Peter Croucher
Multiple Myeloma
Eugenio Morelli
Myeloma
Mala Shanmugam
myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Alec Zhang
myeloma, immunotherapy
Michaela Reagan
Multiple Myeloma
Tanya Siddiqi
clinical trial access
Sham Mailankody
Myeloma immunotherapy clinical trials
Bruno Paiva
smoldering myeloma
Qing Yi
Novel CAR-T
Alfred Garfall
myeloma immunotherapy
Sigurður Kristinsson
Smoldering myeloma
F. Lennie Wong
Equity in Access
Ruben Carrasco
Myeloma
Fenghuang Zhan
Myeloma and bone disease
Jing Yang
Myeloma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
John Leonard
lymphoma research
Carl June
CAR T immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Ricky Johnstone
lymphoma and myeloma
William Matsui
Myeloma
Gareth Morgan
smoldering myeloma, MGUS
Brian Walker
smoldering myeloma, MGUS
Jun Qi
Myeloma
Noemí Puig Morón
Myeloma
Christopher Flowers
clinical trial access
Jing Fu
myeloma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Lawrence Boise
CART and myeloma
Nizar Bahlis
Myeloma immunotherapy
Siegfried Janz
Myeloma immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma
Matteo Bellone
Smoldering multiple myeloma